FDA Approved: DAPTOMYCIN — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Meitheal Pharmaceuticals' generic daptomycin (daptomycin) under an original ANDA (ANDA 213623), authorizing its marketing as a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Complicated Skin and Skin Structure Infections
• Infective Endocarditis

Drugs mentioned

• Daptomycin (daptomycin)

Snippet

ORIG AP for DAPTOMYCIN (DAPTOMYCIN)